Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932471-24-000815
Filing Date
2024-11-12
Accepted
2024-11-12 12:12:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 UnitedStates_13G__4DMolecula.txt SC 13G/A 5009
  Complete submission text file 0000932471-24-000815.txt   6776
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address 100 VANGUARD BLVD MALVERN PA 19355 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Subject) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91921 | Film No.: 241445936
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)